Jan‐Michael Werner

1.3k total citations
58 papers, 779 citations indexed

About

Jan‐Michael Werner is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jan‐Michael Werner has authored 58 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 31 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jan‐Michael Werner's work include Glioma Diagnosis and Treatment (39 papers), Medical Imaging Techniques and Applications (19 papers) and Radiomics and Machine Learning in Medical Imaging (13 papers). Jan‐Michael Werner is often cited by papers focused on Glioma Diagnosis and Treatment (39 papers), Medical Imaging Techniques and Applications (19 papers) and Radiomics and Machine Learning in Medical Imaging (13 papers). Jan‐Michael Werner collaborates with scholars based in Germany, United States and Netherlands. Jan‐Michael Werner's co-authors include Norbert Galldiks, Gereon R. Fink, Karl‐Josef Langen, Philipp Lohmann, Garry Ceccon, N. Jon Shah, Elena K. Bauer, Martin Köcher, Gabriele Stoffels and Pantelis Stavrinou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Jan‐Michael Werner

51 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Michael Werner Germany 17 488 428 211 144 89 58 779
Tobias Blau Germany 14 701 1.4× 520 1.2× 195 0.9× 94 0.7× 115 1.3× 45 936
Arian Lasocki Australia 17 567 1.2× 451 1.1× 192 0.9× 135 0.9× 57 0.6× 60 841
Ziren Kong China 18 395 0.8× 381 0.9× 188 0.9× 231 1.6× 130 1.5× 47 878
Haihui Jiang China 17 515 1.1× 223 0.5× 163 0.8× 98 0.7× 177 2.0× 55 701
Garry Ceccon Germany 15 785 1.6× 728 1.7× 315 1.5× 102 0.7× 92 1.0× 38 983
Jose Carrillo United States 12 439 0.9× 249 0.6× 225 1.1× 212 1.5× 111 1.2× 41 795
Islam Hassan United States 11 307 0.6× 287 0.7× 117 0.6× 83 0.6× 102 1.1× 37 545
Yong Cui China 17 367 0.8× 196 0.5× 272 1.3× 196 1.4× 169 1.9× 59 831
Tomáš Kazda Czechia 16 434 0.9× 259 0.6× 388 1.8× 222 1.5× 189 2.1× 101 1000
Pavel Šlampa Czechia 15 403 0.8× 227 0.5× 340 1.6× 184 1.3× 197 2.2× 92 916

Countries citing papers authored by Jan‐Michael Werner

Since Specialization
Citations

This map shows the geographic impact of Jan‐Michael Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Michael Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Michael Werner more than expected).

Fields of papers citing papers by Jan‐Michael Werner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Michael Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Michael Werner. The network helps show where Jan‐Michael Werner may publish in the future.

Co-authorship network of co-authors of Jan‐Michael Werner

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Michael Werner. A scholar is included among the top collaborators of Jan‐Michael Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Michael Werner. Jan‐Michael Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perreault, Sébastien, Marjolein Geurts, Jasia Mahdi, et al.. (2025). Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas. Neuro-Oncology. 27(11). 2804–2811.
2.
Werner, Jan‐Michael, Jörg Steinbach, Michael Sabel, et al.. (2025). Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l-tyrosine PET. Neuro-Oncology Advances. 7(1). vdaf023–vdaf023. 1 indexed citations
3.
Galldiks, Norbert, et al.. (2025). The role of amino acid PET in the era of checkpoint inhibitors and targeted therapy for brain tumor treatment. Current Opinion in Neurology. 38(6). 681–687.
4.
Galldiks, Norbert, Philipp Lohmann, Jan‐Michael Werner, et al.. (2024). PET imaging of gliomas: Status quo and quo vadis?. Neuro-Oncology. 26(Supplement_9). S185–S198. 13 indexed citations
5.
Galldiks, Norbert, Jan‐Michael Werner, Gabriele Stoffels, et al.. (2024). Evaluation of early metabolic changes following vorasidenib using FET PET in patients with IDH-mutant gliomas. Neuro-Oncology Advances. 6(1). vdae210–vdae210. 1 indexed citations
6.
Werner, Jan‐Michael, Garry Ceccon, Philipp Lohmann, et al.. (2024). MRI and18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis. Journal of Nuclear Medicine. 65(6). 838–844. 2 indexed citations
7.
Ceccon, Garry, Jan‐Michael Werner, Philipp Lohmann, et al.. (2024). P09.12.B INFLUENCE OF PATIENT CHARACTERISTICS AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY ON FET UPTAKE IN THE REFERENCE REGION IN PATIENTS WITH GLIOMAS. Neuro-Oncology. 26(Supplement_5). v53–v53. 1 indexed citations
8.
Galldiks, Norbert, Nathalie L. Albert, Jan‐Michael Werner, et al.. (2023). Advances in PET imaging for meningioma patients. Neuro-Oncology Advances. 5(Supplement_1). i84–i93. 9 indexed citations
9.
Werner, Jan‐Michael, Peter Hau, Patrick Roth, et al.. (2023). P11.20.B ASSOCIATION OF HAND-FOOT SKIN REACTIONS WITH SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH REGORAFENIB. Neuro-Oncology. 25(Supplement_2). ii76–ii77.
10.
Galldiks, Norbert, Frank Angenstein, Jan‐Michael Werner, et al.. (2022). Use of advanced neuroimaging and artificial intelligence in meningiomas. Brain Pathology. 32(2). e13015–e13015. 17 indexed citations
11.
Werner, Jan‐Michael, Elena K. Bauer, Caroline Tscherpel, et al.. (2022). Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET. Neuro-Oncology. 25(5). 984–994. 10 indexed citations
12.
Werner, Jan‐Michael, Johannes Weller, Garry Ceccon, et al.. (2021). Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Clinical Cancer Research. 27(13). 3704–3713. 26 indexed citations
13.
Lohmann, Philipp, Martin Köcher, Elena K. Bauer, et al.. (2020). Feature-based PET/MRI radiomics in patients with brain tumors. Neuro-Oncology Advances. 2(Supplement_4). iv15–iv21. 18 indexed citations
14.
Lohmann, Philipp, Jan‐Michael Werner, Elena K. Bauer, et al.. (2020). FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation. Cancers. 12(12). 3835–3835. 64 indexed citations
15.
Werner, Jan‐Michael, Philipp Lohmann, Gereon R. Fink, Karl‐Josef Langen, & Norbert Galldiks. (2020). Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors. Molecules. 25(6). 1471–1471. 28 indexed citations
16.
Lohmann, Philipp, Jan‐Michael Werner, N. Jon Shah, et al.. (2019). Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients. Cancers. 11(2). 153–153. 42 indexed citations
17.
Galldiks, Norbert, Martin Köcher, Garry Ceccon, et al.. (2019). Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression. Neuro-Oncology. 22(1). 17–30. 85 indexed citations
18.
Werner, Jan‐Michael, Gabriele Stoffels, Jan Borggrefe, et al.. (2019). Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI. European Journal of Nuclear Medicine and Molecular Imaging. 46(9). 1889–1901. 41 indexed citations
19.
Werner, Jan‐Michael, Gabriele Röhn, Boris Krischek, et al.. (2019). Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas. Anticancer Research. 39(5). 2299–2306. 8 indexed citations
20.
Lohmann, Philipp, Pantelis Stavrinou, Elena K. Bauer, et al.. (2018). FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 46(3). 591–602. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Blau Breakdown of academic impact, for papers by Arian Lasocki Breakdown of academic impact, for papers by Ziren Kong Breakdown of academic impact, for papers by Haihui Jiang Breakdown of academic impact, for papers by Garry Ceccon Breakdown of academic impact, for papers by Jose Carrillo Breakdown of academic impact, for papers by Islam Hassan Breakdown of academic impact, for papers by Yong Cui Breakdown of academic impact, for papers by Tomáš Kazda Breakdown of academic impact, for papers by Pavel Šlampa
Rankless by CCL
2026